Effects of mindfulness meditation and Acceptance and commitment therapy in patients with obstructive sleep apnea with residual excessive sleepiness: A randomized controlled pilot study

被引:0
|
作者
Hellrigel-Holderbaum, Max [1 ,2 ,5 ]
Romanczuk-Seiferth, Nina [3 ]
Glos, Martin [1 ]
Fietze, Ingo [1 ,4 ]
机构
[1] Charite Univ med Berlin, Interdisciplinary Ctr Sleep Med, Berlin, Germany
[2] Humboldt Univ, Berlin Sch Mind & Brain, Berlin, Germany
[3] Charite Univ med Berlin, Dept Psychiat & Psychotherapy, Berlin, Germany
[4] Fourth Peoples Hosp Guangyuan, Guangyuan, Peoples R China
[5] Humboldt Univ, Berlin Sch Mind & Brain, Unter Linden 6, D-10099 Berlin, Germany
关键词
Obstructive sleep apnea; Excessive daytime sleepiness; Behavioral therapy; Mindfulness meditation; MBSR; ACT; COGNITIVE-BEHAVIORAL THERAPY; PSYCHOMETRIC PROPERTIES; CHRONIC INSOMNIA; INTERVENTIONS; METAANALYSIS; DISTURBANCE; MANAGEMENT; PROGRAMS; QUALITY; STRESS;
D O I
10.1016/j.sleep.2023.03.022
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Assessing the effects of Mindfulness-Based Stress Reduction (MBSR) on symptoms of OSA, especially on the primary outcome, excessive daytime sleepiness (EDS).Methods: Parallel randomized controlled trial. 16 OSA patients with residual EDS (rEDS) were random-ized and assigned to either a standardized 8-week MBSR program or a time-matched program on Acceptance and Commitment Therapy (ACT). Both programs were conducted online. Participants answered questionnaires online at baseline (pre), post-intervention (post), three months after the intervention (follow-up) and were blinded to whether their group was the treatment or active control group but not to group allocation (partial blinding). Three participants dropped out early. Most analyses are based on the remaining 13 patients.Results: There was a significant difference between the MBSR (n = 7) and ACT group (n = 6) in changes of EDS between pre and post (Cohen's d = 1.24, CI [0.01, 2.42]) and a significant reduction of EDS for pa-tients in the ACT group at post (Cohen's d = 1.18 and [0.08, 2.22]). This EDS reduction averaging 2.17 points on the Epworth Sleepiness Scale reached the prespecified bar for clinical significance of two points on that scale. Insomnia symptoms, a secondary outcome, reduced significantly following ACT (Cohen's d = 1.43 [0.23, 2.58]). In MBSR, both participants and the MBSR-trainer judged movement-based exer-cises to be most efficacious.Conclusion: ACT shows potential as adjunctive therapy for OSA with rEDS, although further studies are needed. It seems promising to develop therapeutic approaches for OSA with rEDS using ACT, especially if they are tailored to the needs specific to this patient group. Trial registration: https://www.drks.de; Identifier: DRKS00026812. (c) 2023 Elsevier B.V. All rights reserved.
引用
收藏
页码:33 / 41
页数:9
相关论文
共 50 条
  • [1] EFFECTS OF DONEPEZIL IN PATIENTS WITH RESIDUAL EXCESSIVE SLEEPINESS OF OBSTRUCTIVE SLEEP APNEA: A DOUBLE BLIND; RANDOMIZED PLACEBO; CONTROLLED STUDY
    Sousa, K. M.
    Piovezan, R. D.
    Silva, L.
    De Melo, C.
    Poyares, D.
    Tufik, S.
    [J]. SLEEP, 2020, 43 : A242 - A242
  • [2] Neurocognitive function in patients with residual excessive sleepiness from obstructive sleep apnea: a prospective, controlled study
    Werli, Ksdy S.
    Otuyama, Leonardo J.
    Bertolucci, Paulo H.
    Rizzi, Camila F.
    Guilleminault, Christian
    Tufik, Sergio
    Poyares, Dalva
    [J]. SLEEP MEDICINE, 2016, 26 : 6 - 11
  • [3] Residual excessive daytime sleepiness in obstructive sleep apnea
    Mayer, Geert
    [J]. SOMNOLOGIE, 2022, 26 (02): : 128 - 135
  • [4] Residual excessive daytime sleepiness in patients with obstructive sleep apnea treated with positive airway pressure therapy
    Shannon N. Foster
    Shana L. Hansen
    Nicholas J. Scalzitti
    Panagiotis Matsangas
    Brian A. Moore
    Vincent Mysliwiec
    [J]. Sleep and Breathing, 2020, 24 : 143 - 150
  • [5] Residual excessive daytime sleepiness in patients with obstructive sleep apnea treated with positive airway pressure therapy
    Foster, Shannon N.
    Hansen, Shana L.
    Scalzitti, Nicholas J.
    Matsangas, Panagiotis
    Moore, Brian A.
    Mysliwiec, Vincent
    [J]. SLEEP AND BREATHING, 2020, 24 (01) : 143 - 150
  • [6] Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3) A Randomized Controlled Trial
    Schweitzer, Paula K.
    Rosenberg, Russell
    Zammit, Gary K.
    Gotfried, Mark
    Chen, Dan
    Carter, Lawrence P.
    Wang, Hao
    Lu, Yuan
    Black, Jed
    Malhotra, Atul
    Strohl, Kingman P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (11) : 1421 - 1431
  • [7] Excessive Daytime Sleepiness and Obstructive Sleep Apnea in Patients With Sarcoidosis
    Patterson, Karen C.
    Huang, Frank
    Oldham, Justin M.
    Bhardwaj, Nakul
    Hogarth, D. Kyle
    Mokhlesi, Babak
    [J]. CHEST, 2013, 143 (06) : 1562 - 1568
  • [8] Residual excessive sleepiness in patients with obstructive sleep apnea on treatment with continuous positive airway pressure
    Dongol, Eptehal M.
    Williams, Adrian J.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2016, 22 (06) : 589 - 594
  • [9] A FUNCTIONAL NEUROIMAGING STUDY OF THE EFFECTS OF ARMODAFINIL ON CORTICAL ACTIVITY AND WORKING MEMORY IN PATIENTS WITH RESIDUAL EXCESSIVE SLEEPINESS ASSOCIATED WITH OBSTRUCTIVE SLEEP APNEA
    Thomas, R. J.
    Greve, D. N.
    Fischl, B. R.
    Yang, R.
    Dayno, J. M.
    Rippon, G. A.
    [J]. SLEEP, 2009, 32 : A190 - A190
  • [10] Pitolisant efficacy in excessive daytime sleepiness for patients with obstructive sleep apnea
    Causse, Christian
    Pepin, Jean-Louis
    Dauvilliers, Yves
    Attali, Valerie
    Lehert, Philippe
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58